To assess detrimental effects on bone mass of long-term treatment with thyroid hormones (TH).
How were differences between studies investigated?
A Q-test for homogeneity was performed. The funnel plot was symmetrical. Studies were analysed separately as either suppressive or replacement thyroid therapy. Suppressive thyroid therapy was defined as: thyroid-stimulating hormone level below the normal range for the assay used in at least 70% of the patients from the given group; or a suppressed response to the thyrotropin-releasing hormone test in at least 70% of patients; or when none of these data were available, a mean daily dose of T4 greater than 200 microg.
Results of the review
Thirty-three studies (95 men, 584 premenopausal women and 682 postmenopausal women) were included: 27 studies were considered, at least in part, to administer suppressive therapy (95 men, 385 premenopausal women and 420 postmenopausal women); 13 studies were considered, at least in part, to deal with the effect of replacement therapy (199 premenopausal and 262 postmenopausal women). 
Authors' conclusions
For lumbar spine and hip, suppressive TH therapy was associated with significant bone loss in postmenopausal women, but not in premenopausal women, whereas conversely, replacement therapy was associated with bone loss in premenopausal women (spine and hip), but not in postmenopausal women. The detrimental effect of TH appeared more marked on cortical bone than on trabecular bone. Only a large long-term prospective placebo-controlled trial of TH therapy evaluating BMD, and ideally fracture rate, would provide further insight into these issues.
CRD commentary
The method for assessing and grouping studies was not reported. In addition, there is a lack of information on the outcomes measured in individual studies. Whilst the funnel plot using all study groups was symmetrical, potential publication bias cannot be ruled out for specific subgroups.
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